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Abstract 
This study was aimed to determine the occurrence of CTX-M-15 and CTX-M-55 producing Escherichia coli 
isolated from milk samples in West Java, Indonesia.  A total of 129 milk samples were collected from diary 
farms from March to April 2016.  Presence of extended-spectrum beta-lactamase (ESBL) producing E. coli was 
detected by disc diffusion test based on the recommendation from Clinical and Laboratory Standards Institute.  
Bacterial strains which were confirmed as producing ESBLs were further analyzed for the presence of bla genes 
of the ESBL by polymerase chain reaction (PCR).  The results showed that CTX-M producing E. coli isolates 
were detected in 4 samples from 129 samples (3.1%).  The β-lactamase genes detected included CTX-M-15 (n = 
3) and CTX-M-55 (n = 1).  All of the CTX-M producing E. coli isolates showed multidrug resistance 
phenotypes to at least three antibiotics.  The highest incidence of antibiotics resistance was against penicillin G 
(100.0%), followed by streptomycin (75.0%), gentamicin (75.0%), tetracycline (75.0%), trimethoprim-
sulfamethoxazole (50.0%), polymyxin B (25.0%), ciprofloxacin (0.0%), and enrofloxacin (0.0%).  The 
occurance of CTX-M ESBL in milk could be a threat towards public health because its ability to spread resistant 
gene to the environment, food, human, animal and other pathogenic bacteria.  
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1. Introduction 
Extended spectrum β-lactamases (ESBLs) are the plasmid mediated enzymes that confer resistance to 3rd and 
4th generation cephalosporins (oxy-imino β-lactam) and monobactam (aztreonam) groups of drugs except 
carbapenems and cephamycins [1].  Production of ESBLs is the most common mechanism of resistance to 3rd 
generation cephalosporins among Enterobacteriaceae including Klebsiella pneumoniae and Escherichia coli [2].  
The CTX-M family of ESBLs have become prominent and are common in Escherichia coli, with many 
infections occurring in human patients in the community.  The first CTX-M ESBL E. coli recovered from food 
producing animals in the UK was an E. coli isolated from diarrhoeic calves on a Welsh dairy farm in 2004 [3].  
CTX-M β-lactamases form a large and still growing family of enzymes which is divided into several groups, 
with several members in each group [4].  Until now more than 600 ESBL variants are known.  Among them, the 
over 100 CTX-M enzymes so far reported may be grouped into five main subgroups (CTX-M-1, M-2, M-8, M-9 
and M-25) based on amino acid sequence similarities [5,6].   
The occurrence of ESBL-producing bacteria has been broadly recognized as causative agents for mastitis in 
dairy cattle [7].  Escherichia coli is one of the most important causative agents for clinical mastitis in lactating 
cows, together with K. pneumoniae, and β-lactam antibiotics are the drugs of choice for treatment.  Improper 
and excessive use of intramammary or parenteral β-lactam antibiotics may provoke bacterial adaptation [8].  
Use of third and fourth generation cephalosporins in livestock is likely to provide a selective pressure for the 
maintenance of resistance or emergence of resistance to these compounds [9].  The emergence of resistant 
bacteria and the transmission of these bacteria from foods to humans have become serious public health 
problems in treating their infection [10,11].  This study was aim to determine the occurrence of CTX-M 
producing E. coli from milk from dairy farms in West Java, Indonesia. 
2. Material and Methods 
2.1. Isolation and Identification of ESBL Producing Escherichia coli 
Isolation and identification of ESBL producing E. coli was done by refering to Sudarwanto and his colleagues 
 [12].  A total of 129 milk samples from 8 districts in West Java, Indonesia were collected from March to April 
2016.  Milk samples were put in sterile tubes and transported to the laboratory using cooling box.  Milk samples 
(10 mL) were enriched for 24 h at 37 °C supplemented with 20 µL cefotaxime (1 µg/mL).  There after the 
enrichment was streaked onto MacConkay agar (Merck 1.05465.0500, Germany) containing 1 mg/L cefotaxime, 
and incubated at 37 °C for 24 h under aerobic condition.  The colonies that ware presumed as E. coli will appear 
as red colonies in the media, and surrounded by turbid zone.  Further works were continued by KOH test, Gram 
staining, oxidase test (Oxoid MB0266A, England), sulfide, indole, and motility (SIM) test, and biochemical test 
[indole, methyl red, Voges-Proskauer, and citrate (IMViC)].  The colonies that were presumed as E. coli were 
selected and sub cultured onto tryptic soy broth (Merck 1.05458.0500, Germany) at 37 °C for 24 h. The 
identification of the E. coli-like colonies were then confirmed using API 32E (Biomerieux). Isolates were stored 
in tryptic soy broth containing 20% glycerol at -20 °C until further workup. 
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2.2. ESBL confirmation and antibiotic susceptibility testing  
All cefotaxime-resistant, and Oxidase-negative, isolates were confirmed for ESBL production by the disk 
diffusion method according to the Clinical Laboratory Standards Institute (CLSI) guidelines [13].  The 
inhibition zones were determined for each isolate, using antibiotic disks, each containing 30 mg of cefotaxime, 
ceftazidime, or cefpodoxime, either alone or in combination with 10 mg of clavulanic acid (MAST Group Ltd., 
Reinfeld, Germany).  E. coli isolates which produced ESBL were subjected to susceptibility testing against 8 
antimicrobial agents (penicillin G, streptomycin, gentamycin, ciprofloxacin, enrofloxacine, tetracycline, 
trimethoprim-sulfamethoxazole, and polymyxin B) with disk diffusion method according to CLSI protocols and 
evaluated with CLSI criteria.  E. coli ATCC 25922 and Klebsiella pneumoniae ATCC 700603 (K. pneumoniae) 
were used as a control strain. 
2.3. Characterization of β-lactamase by polymerase chain reaction (PCR) 
Bacterial strains which were confirmed as producing ESBLs were further analyzed for the presence of bla genes 
of the ESBL subtypes TEM, SHV, and CTX-M (group 1, 2, 8, 9, or 25) by PCR using primers and conditions as 
previously reported [12].  Bacterial DNA was isolated with the DNeasy blood and tissue kit (Qiagen, Hilden, 
Germany) according to the manufacturer's recommendations.  Two strains, K. pneumoniae ATCC 700603 was 
used as standard ESBL-positive strains and a non-ESBLproducing organism (E. coli ATCC 25922) was used as 
negative control.  PCR products were determined by electrophoresis in a 2% agarose gel (Biozym, Hessisch-
Oldendorf, Germany).  The molecular marker GeneRuler 100-bp DNA ladder (MBI Fermentas, St. Leon-Roth, 
Germany) was used. 
2.4. Sequencing of bla genes 
The ESBL-encoding genes blaTEM, blaSHV, and blaCTX-M of the ESBL-positive isolates were amplified with 
primers and PCR conditions as described previously [12].  Resulting amplicons were purified using the PCR 
purification kit (Qiagen).  Sequencing was performed at SeqLab (Goettingen, Germany).  Results were 
evaluated using the BLAST algorithm available at http://blast.ncbi.nlm.nih.gov/Blast.cgi. 
2.5. Data Analysis 
Data were descriptively analyzed to describe occurrence of CTX-M producing E. coli isolated from milk from 
dairy farms in West Java, Indonesia. 
3. Results 
In this present study, 4 ESBL-producing E. coli isolated from milk samples produced CTX-M type ESBL.  The 
blaCTX-M types were identified CTX-M-15 (n = 3) and CTX-M-55 (n = 1).  PCR analysis followed by partial 
sequencing revealed the presence of blaTEM-1 in all of CTX-M type ESBL isolates.  All of CTX-M-15 and CTX-
M-55 producing E. coli isolates showed multidrug resistance phenotypes against at least three antibiotics.  The 
highest incidence of antibiotics resistance was against penicillin G (100.0%), followed by streptomycin (75.0%), 
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gentamicin (75.0%), tetracycline (75.0%), trimethoprim-sulfamethoxazole (50.0%), polymyxin B (25.0%), 
ciprofloxacin (0.0%), and enrofloxacin (0.0%).  Detail results on characteristics and antibiotic susceptibilities of 
multidrug resistant of 4 CTX-M producing E. coli isolates were described in Table 1.  
Table 1  Molecular characterization and antibiotic susceptibilities of ESBL producing E. coli isolates 
No  Code 
bla gene product 
 Antibiotic resistancea  
Totalb 
 
β-
lac-
tam 
 
Amino-
glycosi-
des 
 Fluoroqui-nolones  
Tetra-
cycline  
Folic 
acid 
inhibi-
tor 
 Lipopep-tide 
 
CTX-
M Other 
 P   S  CN   CIP  ENR   TE   STX   PB  R I S 
1 15 CTX-
M-55 
TEM-1  R  R S  S I  S  R  R  4 1 3 
2 22 CTX-
M-15 
TEM-1  R  I R  S S  R  S  S  3 1 4 
3 26 CTX-
M-15 
TEM-1  R  R R  S S  R  I  S  4 1 3 
4 27 CTX-
M-15 
TEM-1  R  R R  S S  R  R  S  5 0 3 
a P: penicillin G; S: streptomycin; CN: gentamicin; CIP: ciprofloxacin; ENR: enrofloxacin; TE: tetracycline; STX: trimethoprim-
sulfamethoxazole; PB: polymyxin B 
b R: resistance; I: Intermediate; S: sensitive 
4. Discussion 
CTX-M producing E. coli isolates were detected in 4 of the 129 (3.1%) milk samples.  In this work, the β-
lactamase genes were detected in these isolates were blaCTX-M-15 (75.0%) and blaCTX-M-55 (25.0%).  All of them 
harbored an additional blaTEM-1 gene but none of them was positive for the blaSHV gene.   
In previous study was analyzed for the presence of ESBL producing Enterobacteriaceae isolated from bulk tank 
milk from diary farms in Indonesia.  The result showed that blaCTX-M-15 genes were detected in 2 of the 7 K. 
pneumoniae isolates.  The relatively high frequency (8.75% (7/80)) of ESBL-producing K. pneumoniae in raw 
bulk tank milk from West Java imply the risk that milk is both a source of local exposure and a vector 
contributing to the supraregional spread of antibiotic-resistant bacteria by trade [8].  Another study in Germany 
showed that ESBL producing E. coli isolates were detected 5.9% (51/866) from bulk tank milk samples.  In this 
study reported that CTX-M was also predominant sequence type among ESBL producing E. coli isolated from 
milk samples.  The results indicated that the ESBL-positive isolates possibly carried the genes for blaCTX-M-1 and 
blaCTX-M-15.  Both enzymes are commonly found in clinical isolates from humans, while blaCTX-M-15 so far has 
only sporadically been reported for isolates from dairy cattle and milk [4].  CTX-M producing E. coli also have 
been isolated from cattle in Japan (CTX-M-2; [14]), Switzerland (CTX-M-14; [6]), Bavarian, Germany (CTX-
M-1, CTX-M-2, and CTX-M-9; [15]), Turkey (CTX-M-1, CTX-M-3 and CTX-M-15; [16]), and Egypt (CTX-
M-15 and CTX-M-9; [17]). 
A possible role for cephalosporin use (ceftiofur, cefoperazone and cefquinome) in the widespread occurrence of 
CTX-M-1 producing E. coli at a dairy farm has recently been suggested.  The original isolation of a CTX-M-15 
E. coli was made in 2006, and since then many cattle, at different stages of production, particularly milking 
cows, had received intra-mammary and injectable veterinary medicines containing third and fourth generation 
cephalosporins [18].  CTX-M-55 differs from CTX-M-15 only by a single amino acid substitution (valine for 
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alanine) at position 80 (Ala80Val).  Therefore, CTX-M-55 is expected to have similar hydrolytic activity as 
CTX-M-15 and to exhibit increased catalytic efficiency against ceftazidime as well as cefotaxime.  Previous 
studies have reported that CTX-M-55-producing isolates generally show high resistance to ceftazidime (MIC 
range from 32 to > 256 µg/mL) [19].  The results may suggest that the injudicious use of antimicrobial agents 
among livestock and hospitals may result in mutation and subsequent epidemiological change of major ESBL 
genotypes circulated (e.g. CTX-M-3 to CTX-M-15 and CTX-M-55) [20].   
Multidrug resistance (MDR) to other classes of antibiotics was also described in this study.  Multidrug 
resistance was defined as resistance to three or more different classes of antimicrobials [21].  This study showed 
that all of CTX-M producing E. coli displayed MDR to at least three antibiotics.  A similar finding was also 
reported by the author in [16], who found that 84.6% (22/26) ESBL/AmpC producing E. coli isolated from 
cattle were also resistant to other class of antimicrobials agents.  This could partly be explained by the fact that 
the plasmids harboring ESBL genes frequently carry other resistance genes that are responsible for other class 
antimicrobials, such as fluoroquinolones, aminoglycosides and trimethoprim-sulphamethoxazole [6, 16]. 
In Indonesia, there are few restrictions concerning the use of antibiotics, neither in human medicine nor in 
veterinary medicine.  Thus, it may be suspected that the rapidly increasing incidence of multidrug-resistant 
bacteria could be a result of the unconscious and extensive use of antibiotics in this country [8].  In this country, 
waste milk cannot be sold for human consumption, but is widely used to feed calves.  Waste milk is milk unfit 
for human consumption and may be designated unfit for various reasons. It includes milk from cows 
immediately post-calving (colostrum), milk from cows with udder infections (mastitis) and milk from cows 
undergoing treatment with antibiotics or other medicines in which drug residues in excess of Maximum Residue 
Limits may be present [9].  Feeding waste milk containing antibiotic resiudues to calves can increase the 
prevalence of CTX-M-positive E. coli in the farm environment due to increased shedding [22].  Another major 
problem raises up in this context, the resistance genes are usually found on plasmids and such mobile elements 
can be easily transferred to and between environmental bacteria as well as to other human pathogens. This poses 
a high risk to the environment, and the human population [17]. 
The rapid proliferation and worldwide spread of CTX-M-type ESBL in E. coli is a matter of concern both in 
human and veterinary medicine.  Furthermore, it has been reported that plasmids carrying CTX-M enzymes can 
transfer these determinants to other commensal Enterobacteriaceae, such as K. pneumoniae, or to pathogens like 
Shigella or Salmonella spp. [12].  Their occurrence in milk can be a significant risk to consumers and animal 
handlers who may get such infection easily.  On the other hand, persistence of such pathogen in udder or milk 
may complicate the therapeutic regimen of intra-mammary infection and clinical recovery of the animals.  The 
pathogens may also disseminate to other in-contact animals via infected milk and contaminate the surrounding 
environment aggravating the situation further, if adequate precautionary measures are not taken [1]. 
Organism producing ESBL is estimated to increase in the future, both in animals and humans.  The use of 
antibiotics requires the policy as issued internationally towards control of zoonotic pathogens [23].  To prevent 
the spreading of these isolates, the use of cephalosporins and fluoroquinolones should be limited in treating cow 
infection isolates, and enhanced sanitation of milk processing and transportation is needed [10].  Heat treatment 
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of milk, either by pasteurization or by ultrahigh temperature treatment safely inactivates Enterobacteriaceae [4]. 
5. Conclusion 
CTX-M-15 and CTX-M-55 producing E. coli are the most prevalent type of our CTX-M ESBL-positive isolates 
and all of CTX-M producing E. coli isolates showed multidrug resistance phenotypes to at least three 
antibiotics.  The existence of CTX-M producing E. coli could be a threat towards public health because its 
ability to spread resistant gene to the environment, food, human, animal and other pathogenic bacteria. 
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